Spearhead Capital Advisors’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-3,259
| Closed | -$244K | – | 152 |
|
|
2022
Q2 | $244K | Sell |
3,259
-50
| -2% | -$3.74K | 0.04% | 148 |
|
|
2022
Q1 | $258K | Sell |
3,309
-1,875
| -36% | -$146K | 0.03% | 160 |
|
|
2021
Q4 | $467K | Buy |
5,184
+52
| +1% | +$4.68K | 0.06% | 105 |
|
|
2021
Q3 | $475K | Sell |
5,132
-27
| -0.5% | -$2.5K | 0.06% | 102 |
|
|
2021
Q2 | $401K | Buy |
5,159
+847
| +20% | +$65.8K | 0.05% | 139 |
|
|
2021
Q1 | $321K | Buy |
4,312
+2,370
| +122% | +$176K | 0.05% | 151 |
|
|
2020
Q4 | $331K | Buy |
1,942
+71
| +4% | +$12.1K | 0.05% | 134 |
|
|
2020
Q3 | $263K | Buy |
1,871
+113
| +6% | +$15.9K | 0.05% | 149 |
|
|
2020
Q2 | $282K | Buy |
+1,758
| New | +$282K | 0.06% | 113 |
|